We found that Tnfr2 KD or the use of anti-TNFR2 antibodies could inhibit cancer cell proliferation directly, and induced the apoptosis of tumor cells in pancreatic cancer. Here, TNFRSF1B is linked to familial pancreatic carcinoma.